FDA Approved: BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE — Supplemental Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

The FDA approved a supplemental application for Budesonide and Formoterol Fumarate Dihydrate from AstraZeneca, updating the product’s labeling and/or indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Budesonide and Formoterol Fumarate Dihydrate (Budesonide and Formoterol Fumarate Dihydrate)

Snippet

SUPPL AP for BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE (BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE)